FI882160A0 - Azaindol- och indolizinderivat, foerfaranden foer deras framstaellning samt deras anvaendning som laekemedel. - Google Patents

Azaindol- och indolizinderivat, foerfaranden foer deras framstaellning samt deras anvaendning som laekemedel.

Info

Publication number
FI882160A0
FI882160A0 FI882160A FI882160A FI882160A0 FI 882160 A0 FI882160 A0 FI 882160A0 FI 882160 A FI882160 A FI 882160A FI 882160 A FI882160 A FI 882160A FI 882160 A0 FI882160 A0 FI 882160A0
Authority
FI
Finland
Prior art keywords
deras
indolizinderivat
azaindol
och
anvaendning som
Prior art date
Application number
FI882160A
Other languages
English (en)
Other versions
FI882160A (fi
Inventor
Paul Leroy Anderson
Faizulla Gulamhusein Kathawala
Nicholas Andrew Paolella
Sompong Wattanasin
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/945,750 external-priority patent/US4751235A/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI882160A publication Critical patent/FI882160A/fi
Publication of FI882160A0 publication Critical patent/FI882160A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI882160A 1986-09-10 1988-05-09 Azaindol- och indolizinderivat, foerfaranden foer deras framstaellning samt deras anvaendning som laekemedel. FI882160A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90589786A 1986-09-10 1986-09-10
US06/945,750 US4751235A (en) 1986-12-23 1986-12-23 Anti-atherosclerotic indolizine derivatives
PCT/EP1987/000511 WO1988001997A2 (en) 1986-09-10 1987-09-09 Azaindole and indolizine derivatives, processes for their production and their use as pharmaceuticals

Publications (2)

Publication Number Publication Date
FI882160A FI882160A (fi) 1988-05-09
FI882160A0 true FI882160A0 (fi) 1988-05-09

Family

ID=27129444

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882160A FI882160A0 (fi) 1986-09-10 1988-05-09 Azaindol- och indolizinderivat, foerfaranden foer deras framstaellning samt deras anvaendning som laekemedel.

Country Status (12)

Country Link
EP (1) EP0265640A3 (fi)
JP (1) JPH01500834A (fi)
KR (1) KR880701719A (fi)
AU (1) AU606621B2 (fi)
DK (1) DK254488A (fi)
FI (1) FI882160A0 (fi)
HU (1) HU200769B (fi)
IL (1) IL83821A0 (fi)
NZ (1) NZ221717A (fi)
PL (1) PL267646A1 (fi)
PT (1) PT85662B (fi)
WO (1) WO1988001997A2 (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352575A3 (de) * 1988-07-28 1991-08-21 Bayer Ag Substituierte anellierte Pyrrole
IL91941A (en) * 1988-10-13 1994-10-21 Sandoz Ag Preparation of 6-Anoic and 7-Metanoic Fatty Acids and Their Substances and Intermediate Compounds and Acid 7-] 3-) 4-Fluorophenyl (-1-) 1- Methylethyl (a)
JPH04270285A (ja) * 1988-11-14 1992-09-25 Nissan Chem Ind Ltd ピラゾロピリミジン系メバロノラクトン類
US5025000A (en) * 1990-03-02 1991-06-18 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-CoA reductase inhibitor compounds
US5124453A (en) * 1990-03-02 1992-06-23 E. R. Squibb & Sons, Inc. Process for preparing certain 5,6,7,8-tetrahydroindolizinyl (ethyl or ethynyl)-hydroxy or methoxy-phosphinyl-3-hydroxy-butanoates and derivatives thereof
WO1992019239A1 (en) * 1991-05-01 1992-11-12 University Of New Mexico Treatment of aberrant cellular states with biomodulators
WO1992019240A1 (en) * 1991-05-01 1992-11-12 University Of New Mexico Treatment of aberrant cellular states with biomodulators
FR2687402B1 (fr) * 1992-02-14 1995-06-30 Lipha Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
EP1535922A4 (en) 2002-07-11 2006-10-04 Takeda Pharmaceutical PYRROLOPYRIDINE DERIVATIVE AND ITS USE
TWI471133B (zh) 2004-03-30 2015-02-01 Vertex Pharma 適合作為ｊａｋ及其它蛋白質激酶抑制劑之氮雜吲哚
AU2007207533B8 (en) 2006-01-17 2012-06-28 Vertex Pharmaceuticals Incorporated Azaindoles useful as inhibitors of Janus kinases
KR20090091350A (ko) 2006-12-21 2009-08-27 버텍스 파마슈티칼스 인코포레이티드 단백질 키나제 억제제로 유용한 ５-시아노-４-피롤로[２,３ｂ]피리딘-３-일)-피리디민 유도체
TWI639596B (zh) 2009-06-17 2018-11-01 維泰克斯製藥公司 流感病毒複製之抑制劑
CA2822057A1 (en) 2010-12-16 2012-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
EP3578554A1 (en) 2013-11-13 2019-12-11 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
LT3421468T (lt) 2013-11-13 2021-01-11 Vertex Pharmaceuticals Incorporated Gripo virusų replikacijos inhibitorių paruošimo būdai
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
MA42422A (fr) 2015-05-13 2018-05-23 Vertex Pharma Inhibiteurs de la réplication des virus de la grippe

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI61030C (fi) * 1976-02-19 1982-05-10 Sanofi Sa Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat
JPS5559180A (en) * 1978-10-30 1980-05-02 Sankyo Co Ltd 4-hydroxy-2-pyrone ring compound, its preparation, and remedy for hyperlipemia comprising it as active constituent
US4474971A (en) * 1982-09-29 1984-10-02 Sandoz, Inc. (Tetrahydropyran-2-yl)-aldehydes
AU570021B2 (en) * 1982-11-22 1988-03-03 Novartis Ag Analogs of mevalolactone
EP0117228B1 (en) * 1983-01-24 1986-11-05 Sandoz Ag Analogs of mevalonolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US4571428A (en) * 1983-07-08 1986-02-18 Sandoz, Inc. 6-Substituted-4-hydroxy-tetrahydropyran-2-ones
AU573368B2 (en) * 1984-06-22 1988-06-02 Sandoz Ag Pyrazole analogs of mevalonolactone and derivatives thereof, process for their production and their use
US4677211A (en) * 1984-06-29 1987-06-30 Sandoz Pharmaceuticals Corp. Preparation of lactones
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs

Also Published As

Publication number Publication date
HU200769B (en) 1990-08-28
PT85662A (en) 1987-10-01
EP0265640A2 (en) 1988-05-04
KR880701719A (ko) 1988-11-04
PT85662B (pt) 1990-06-29
IL83821A0 (en) 1988-02-29
JPH01500834A (ja) 1989-03-23
HUT46914A (en) 1988-12-28
FI882160A (fi) 1988-05-09
PL267646A1 (en) 1988-07-21
NZ221717A (en) 1990-08-28
EP0265640A3 (en) 1988-05-18
AU606621B2 (en) 1991-02-14
AU8022187A (en) 1988-04-07
DK254488D0 (da) 1988-05-09
WO1988001997A2 (en) 1988-03-24
DK254488A (da) 1988-06-24
WO1988001997A3 (en) 1988-04-07

Similar Documents

Publication Publication Date Title
FI870614A0 (fi) Haerdbara blandningar, vilka innehaoller n-sulfonylaminosulfoniumsalter som kationiskt verksamma katalysatorer.
FI870056A (fi) Diarylalkyl-substituerade alkylaminer, foerfaranden foer deras framstaellning, deras anvaendning, samt dessa innehaollande laekemedel.
FI874125A0 (fi) Tvaettmedelskompositioner, vilka innehaoller polyalkylenglykol-iminodiaettiksyra som stoedsubstans.
FI883175A0 (fi) Displayfoersett elektroniskt maolspel, som sjaelv raeknar poaeng.
FI873897A (fi) Maenniskans erytropoietin som framstaellts medelst rekombinations-dna-teknik.
FI873054A (fi) Hydroformylering som utnyttjar litet flyktiga fosfinligander loesliga i organiska aemnen.
FI861396A0 (fi) Braedparkett som isolerar stegljudet.
FI893557A (fi) Polyestrar, som innehaoller en eterbrygga.
FI882160A0 (fi) Azaindol- och indolizinderivat, foerfaranden foer deras framstaellning samt deras anvaendning som laekemedel.
FI860983A (fi) Broms som maetar moment, saerskilt foer hissar.
FI874465A (fi) Uppvaermningsanordning som anvaender mikrovaogsenergi.
FI864835A (fi) Kaerllock som foerhindrar inaotdragning.
FI885070A (fi) Fotohaerdbar elektrostatisk tryckskiva, som innehaoller elektronacceptor eller -donator.
FI862476A0 (fi) Zinkbaserade maolfaerger, i vilka anvaends en blandning av eteralkoholer som flytande organiskt loesningsmedel.
FI861250A (fi) Organiskt ester- och diestertillsatsmedel, som foerhindrar kristallisation av metyltriasetoxisilanet i enkomponents organopolysiloxankompositioner.
FI843139A0 (fi) Foerfarande foer framstaellning dihydrokarbylkarbonater, deras anvaendning som tillsatsmedel i braenslen samt dessa innehaollande braensleblandningar.
FI881241A0 (fi) Laettkonstruktionskaerna, saerskilt som stoedkaerna i skida.
FI884154A (fi) Elmaskin, som innefattar slitskilar.
FI872248A (fi) Lyssatsisolering, saett att framstaella densamma samt i enlighet daermed framstaelld lysladdning.
FI884105A (fi) N-/substituerad-alkyliden/ fusionerad-bicykloalkyliden- och heteroalkylidenkinolinaminer, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel.
FI860782A0 (fi) Motionsredskap, tillaeggsanordning foer detta samt anvaendning av redskapet.
FI861519A (fi) Lakutrustning som lossas hydrauliskt.
FI865175A0 (fi) Specialmatta som glidyta.
FI923164A (fi) Foereningar anvaendbara som mellan- produkter.
FI884358A0 (fi) Handverktyg som utfoer fram- och tillbakagaoende roerelse, speciellt en metallsaog.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: SANDOZ AG